
Tesamorelin
Tesamorelin is a growth hormone-releasing factor analog used in FDA-approved prescription products for excess abdominal fat in adults with HIV-associated lipodystrophy.
Adipose tissue research and product-specific clinical context

Tesamorelin is a growth hormone-releasing factor analog used in FDA-approved prescription products for excess abdominal fat in adults with HIV-associated lipodystrophy.

AOD-9604 is a modified fragment related to the C-terminal region of human growth hormone.

Tirzepatide is a prescription peptide that activates two incretin receptors, GIP and GLP-1.

Semaglutide is a GLP-1 receptor agonist available in multiple prescription products.

MOTS-c is a short peptide associated with mitochondrial genetic signaling.
A proposed mechanism, a laboratory finding, and a patient outcome answer different questions. Read the study population and design before applying a result to a new setting
How to read the evidence ↗